First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy- β-phenylalanine S

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 5, 1999, Pages 691-696

  Kim, D H ^a   Jin, Y ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE A INHIBITOR; HYDROXAMIC ACID DERIVATIVE; N ACYL N HYDROXY BETA PHENYLALANINE DERIVATIVE; N PHENYLACETYL N HYDROXY BETA PHENYLALANINE; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INACTIVATION;

EID: 0033535406     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00055-4     Document Type: Article

References (23)

1. J.C. Powers J.W. Harper A.J. Barrett G. Salvesen Proteinase Inhibitors 1986 Elsevier Amsterdam 224 225
2. G. Anderegg F. L'Eplattenier G. Schwarzenbach Helv. Chim. Acta 46 1963 1400 1408
3. B. Kurzak H. Kozolowski E. Farkas Coord. Chem. Rev. 114 1992 169 200
4. N. Nishino J.C. Powers Biochemistry 17 1978 2846 2850
5. N. Nishino J.C. Powers Biochemistry 18 1979 4340 4347
6. L. Turbanti G. Cerbai C. Di Bugno R. Giorgi G. Garzelli M. Criscuoli A.R. Renzetti A. Subissi G. Bramanti J. Med. Chem. 36 1993 699 707
7. A. Rockwell M. Melden R.A. Copeland K. Hardman C.P. Decicco W.F. DeGrado J. Am. Chem. Soc. 118 1996 10337 10338
8. M. Yamamoto H. Tsujishita N. Hori Y. Ohishi S. Inoue S. Ikeda Y. Okada J. Med. Chem. 41 1998 1209 1217
9. N. Nishino J.C. Powers J. Biol. Chem. 255 1980 3482 3486
10. T.D. Penning L.J. Askonas S.W. Djuric R.A. Haak S.S. Yu M.L. Michener G.G. Krivi E.Y. Pyla Bioorg. Med. Chem. Lett. 5 1995 2517 2522
11. R. Bouboutou G. Waksman J. Devin M.-C. Fournie-Zaluski B. Roques Life Sci. 35 1984 1023 1030
12. D.V. Patel M.G. Young S.P. Robinson L. Hunihan B.J. Dean E.M. Gordon J. Med. Chem. 39 1996 4197 4210
13. Most of reported hydroxamate-bearing inhibitors for zinc-containing enzymes are in the form of HN(OH)-CO-R in which R represents oligopeptides which can be accommodated in the binding subsites of the target enzymes J.C. Powers J.W. Harper A.J. Barrett G. Salvesen Proteinase Inhibitors 1986 Elsevier Amsterdam 244 253
14. W.K. Hagmann M.W. Lark J.W. Becker Ann. Rep. Med. Chem. 31 1996 231 240
15. D.W. Christianson W.N. Lipscomb Acc. Chem. Res. 22 1989 62 69
16. Y. Jin D.H. Kim Synlett 1998 1189 1190
17. A. Fersht Enzyme Structure and Mechanism 2nd ed. 1977 W. H. Freeman & Co New York 108 109
18. M. Dixon Biochem. J. 55 1953 170 171
19. Y. Jin D.H. Kim Bioorg. Med. Chem. Lett. 8 1998 3515 3518
20. The three-dimensional structures of thermolysin remains practically unchanged upon forming complexes with inhibitors, suggesting the enzyme bears a rigid structural frame: W.R. Kester B.W. Matthews J. Biol. Chem. 252 1977 7704 7710
21. B.W. Matthews Acc. Chem. Res. 21 1988 333 340
22. C.A. McPhalen N.C.J. Strynadka M.N.G. James Adv. Protein Chem. 42 1991 77 144
23. M.A. Holmes D.E. Tronrud B.W. Matthews Biochemistry 22 1983 236 240